GR3020848T3 - 1,8-Naphthyridin-2-one derivatives - Google Patents

1,8-Naphthyridin-2-one derivatives

Info

Publication number
GR3020848T3
GR3020848T3 GR960402205T GR960402205T GR3020848T3 GR 3020848 T3 GR3020848 T3 GR 3020848T3 GR 960402205 T GR960402205 T GR 960402205T GR 960402205 T GR960402205 T GR 960402205T GR 3020848 T3 GR3020848 T3 GR 3020848T3
Authority
GR
Greece
Prior art keywords
substituted
lower alkyl
chem
single bond
unsubstituted
Prior art date
Application number
GR960402205T
Other languages
English (en)
Inventor
Fumio Suzuki
Takeshi Kuroda
Kenji Ohmori
Tadafumi Tamura
Hisashi Hosoe
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Publication of GR3020848T3 publication Critical patent/GR3020848T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
GR960402205T 1990-04-16 1996-08-22 1,8-Naphthyridin-2-one derivatives GR3020848T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10000690 1990-04-16

Publications (1)

Publication Number Publication Date
GR3020848T3 true GR3020848T3 (en) 1996-11-30

Family

ID=14262483

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960402205T GR3020848T3 (en) 1990-04-16 1996-08-22 1,8-Naphthyridin-2-one derivatives

Country Status (9)

Country Link
US (1) US5126341A (el)
EP (1) EP0452873B1 (el)
JP (1) JP2988739B2 (el)
AT (1) ATE140003T1 (el)
CA (1) CA2040517C (el)
DE (1) DE69120581T2 (el)
DK (1) DK0452873T3 (el)
ES (1) ES2093041T3 (el)
GR (1) GR3020848T3 (el)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219864A (en) * 1991-03-12 1993-06-15 Kyowa Hakko Kogyo Co., Ltd. Thienopyridine derivatives
GB9127252D0 (en) * 1991-12-23 1992-02-19 Boots Co Plc Therapeutic agents
DE4227747A1 (de) * 1992-08-21 1994-02-24 Basf Ag Heteroaromatisch kondensierte Hydroxypyridoncarbonsäureamide, deren Herstellung und Verwendung
GB9312891D0 (en) * 1993-06-22 1993-08-04 Boots Co Plc Therapeutic agents
GB9318931D0 (en) * 1993-09-14 1993-10-27 Boots Co Plc Therapeutic agents
GB9409264D0 (en) * 1994-05-10 1994-06-29 Boots Co Ltd Therapeutic agents
GB9420172D0 (en) * 1994-10-06 1994-11-23 Boots Co Plc Therapeutic agents
GB9420168D0 (en) * 1994-10-06 1994-11-23 Boots Co Plc Therapeutic agents
EA011719B1 (ru) * 2000-12-18 2009-04-28 Институт Оф Медисинал Молекьюлар Дизайн, Инк. Ингибитор высвобождения воспалительного цитокина
DE10222895A1 (de) * 2002-05-23 2003-12-11 Bosch Gmbh Robert Hochdruckspeicher für Kraftstoffeinspritzsysteme mit integriertem Druckregelventil
US20060100257A1 (en) * 2002-06-05 2006-05-11 Susumu Muto Inhibitors against the activation of ap-1 and nfat
JPWO2003103658A1 (ja) * 2002-06-05 2005-10-06 株式会社医薬分子設計研究所 免疫関連プロテインキナーゼ阻害剤
EA008769B1 (ru) * 2002-06-05 2007-08-31 Инститьют Оф Медисинал Молекьюлар Дизайн. Инк. Лекарственное средство для лечения диабета
WO2003103665A1 (ja) 2002-06-06 2003-12-18 株式会社医薬分子設計研究所 抗アレルギー薬
EP1512397B1 (en) 2002-06-06 2014-10-08 Institute of Medicinal Molecular Design, Inc. O-substituted hydroxyaryl derivatives
EA010835B1 (ru) * 2002-06-10 2008-12-30 Инститьют Оф Медисинал Молекьюлар Дизайн. Инк. Лекарственное средство для лечения рака
TW200410675A (en) * 2002-06-10 2004-07-01 Inst Med Molecular Design Inc An NF-κB activation inhibitor
EP1555018A4 (en) * 2002-06-11 2009-01-07 Inst Med Molecular Design Inc MEANS FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES
DE60320297T2 (de) * 2002-11-12 2009-07-16 Nok Corp. Gummiartiges elastisches teil
EP2111399A2 (en) * 2006-12-18 2009-10-28 Amgen Inc. Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
US8048892B2 (en) * 2006-12-18 2011-11-01 Amgen Inc. Azaquinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
US8048894B2 (en) * 2007-04-18 2011-11-01 Amgen Inc. Quinolones and azaquinolones that inhibit prolyl hydroxylase
CA2683738C (en) * 2007-04-18 2012-03-20 Amgen Inc. Indanone derivatives that inhibit prolyl hydroxylase
US8097620B2 (en) * 2007-05-04 2012-01-17 Amgen Inc. Diazaquinolones that inhibit prolyl hydroxylase activity
ES2389063T3 (es) * 2007-05-04 2012-10-22 Amgen, Inc Derivados de tienopiridina y tiazolopiridina que inhiben la actividad prolil hidroxilasa
EP2855479B1 (en) * 2012-04-05 2016-03-30 Boehringer Ingelheim International GmbH 1,8-naphthyridin-2(1h)-one derivatives as cytomegalovirus inhibitors
AU2021266732A1 (en) 2020-05-05 2023-01-05 Teon Therapeutics, Inc. Cannabinoid receptor type 2 (CB2) modulators and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3591584A (en) * 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
US4264602A (en) * 1975-08-15 1981-04-28 Sandoz, Inc. 4-Hydroxy-3-nitro-pyrido[2,3-B]pyridine-2(1H)-ones
DE2635216A1 (de) * 1975-08-15 1977-03-03 Sandoz Ag 4-hydorxy-3-nitropyrido eckige klammer auf 2,3-b eckige klammer zu pyridin2-one und ihre herstellung
US4128649A (en) * 1977-06-29 1978-12-05 Sandoz, Inc. 4-Hydroxy-pyrido[2,3-b]pyridine-2(1H)-one-3-carboxylic acids and esters
US4215123A (en) * 1979-05-07 1980-07-29 American Home Products Corporation Antisecretory 4-oxy-3-carboxy or cyano-1,2-dihydro-2-oxo-1,8-naphthyridine derivatives
EP0092786B1 (en) * 1982-04-26 1987-01-07 Schering Corporation 1,8-naphthyridine and 1,5,8-azanaphthyridine derivatives
CA1305478C (en) * 1986-11-06 1992-07-21 Margaret H. Sherlock Naphthyridine and pyridopyrazine compounds and pharmaceutical usage thereof

Also Published As

Publication number Publication date
JPH04217981A (ja) 1992-08-07
CA2040517C (en) 1997-06-03
DE69120581D1 (de) 1996-08-08
CA2040517A1 (en) 1991-10-17
JP2988739B2 (ja) 1999-12-13
EP0452873A1 (en) 1991-10-23
ES2093041T3 (es) 1996-12-16
DK0452873T3 (da) 1996-07-29
EP0452873B1 (en) 1996-07-03
DE69120581T2 (de) 1996-10-31
ATE140003T1 (de) 1996-07-15
US5126341A (en) 1992-06-30

Similar Documents

Publication Publication Date Title
GR3020848T3 (en) 1,8-Naphthyridin-2-one derivatives
NO174711C (no) Analogifremgangsmåte for fremstilling av nye, terapeutisk aktive pyrimidindionderivater
CA2124680A1 (en) Piperazine derivatives as 5-ht1a antagonists
FI892497A (fi) Menetelmä terapeuttisesti aktiivisten bentsamidijohdannaisten valmistamiseksi
DK0790987T3 (da) Aminotetrazol-derivater, der er anvendelige som nitrogenoxidsynthaseinhibitorer
FI900461A0 (fi) Imidazopyridaziner, deras framstaellning och anvaendning.
ATE252074T1 (de) Phenylalkylcarbonsäure-derivate
DE68911773T2 (de) Benzimidazol-Derivate mit pharmakologischer Aktivität.
NO940312D0 (no) Nytt bisheterocyklisk derivat eller salt derav
IS3828A (is) Hliðstæð aðferð til tilreiðslu á nýjum afleiðum thiazolidinone og oxazolidinone sem gagnlegar eru til æðaútvíkkunar
ATE146476T1 (de) Cephalosporinverbindungen und verfahren zu ihrer herstellung
GB2254324B (en) Piperazine derivatives